Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1275 CAD | -1.92% | -5.56% | -1.92% |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.92% | 38.07M | - | ||
+37.37% | 6.02B | B- | ||
-15.69% | 4.49B | C+ | ||
-12.46% | 3.06B | B- | ||
-0.12% | 3.04B | C | ||
+0.47% | 2.61B | - | D+ | |
+36.06% | 1.81B | - | ||
+0.84% | 1.66B | - | - | |
-10.60% | 1.63B | - | - | |
-12.03% | 1.55B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- DB Stock
- Ratings Decibel Cannabis Company Inc.